174 related articles for article (PubMed ID: 33456260)
1. Comparative analysis of nucleomorphometric parameters in methyl green-pyronin-stained sections of oral epithelial dysplasia, oral submucous fibrosis and oral squamous cell carcinoma.
Singh E
J Oral Maxillofac Pathol; 2020; 24(2):401. PubMed ID: 33456260
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphometric analysis of oral submucous fibrosis and leukoplakia using methyl green-pyronin Y, Feulgen staining and exfoliative brush cytology.
Metgud R; Gupta K; Prasad U; Gupta J
Biotech Histochem; 2015 Jan; 90(1):8-13. PubMed ID: 24867495
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of nucleoproteins and comparison of methyl green-pyronin Y and Feulgen staining in sections of oral squamous cell carcinoma, dysplastic lesions and normal mucosa.
Metgud R; Gupta K; Chandra U
Biotech Histochem; 2014 May; 89(4):267-72. PubMed ID: 24219353
[TBL] [Abstract][Full Text] [Related]
4. A histochemical comparison of methyl green-pyronin, and hematoxylin and eosin for detecting apoptotic cells in oral squamous cell carcinoma, oral leukoplakia, oral submucous fibrosis and normal oral mucosa.
Sumedha S; Kotrashetti VS; Somannavar P; Nayak R; Babji D
Biotech Histochem; 2015 May; 90(4):264-9. PubMed ID: 25539051
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
Kalaimani G; Rao UDK; Joshua E; Ranganathan K
Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63 in potentially malignant and malignant oral lesions.
Sinha A; Chandra S; Raj V; Zaidi I; Saxena S; Dwivedi R
J Oral Biol Craniofac Res; 2015; 5(3):165-72. PubMed ID: 26605141
[TBL] [Abstract][Full Text] [Related]
7. The Diagnostic Role of Methyl Green-Pyronin Y Staining in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Exfoliative Cytology-Based Cytomorphometric Analysis.
Raman RK; Kamboj M; Narwal A
Acta Cytol; 2019; 63(5):401-410. PubMed ID: 31112943
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
9. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
10. Detection of nucleoproteins in squamous cell carcinoma, and dysplastic and normal mucosa in the oral cavity by methyl green-pyronin staining.
Mohtasham N; Mahdavi-Shahri N; Salehinejad J; Ejtehadi H; Torabi-Parizi M; Ghazi N
J Oral Sci; 2010 Jun; 52(2):239-43. PubMed ID: 20587947
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
12. Caspase-3 expression in normal oral epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
Veeravarmal V; Austin RD; Siddavaram N; Thiruneelakandan S; Nassar MH
J Oral Maxillofac Pathol; 2016; 20(3):445-452. PubMed ID: 27721610
[TBL] [Abstract][Full Text] [Related]
13. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Raghunandan BN; Sanjai K; Kumaraswamy J; Papaiah L; Pandey B; Jyothi BM
J Oral Maxillofac Pathol; 2016; 20(1):96-101. PubMed ID: 27194869
[TBL] [Abstract][Full Text] [Related]
14. Current challenges and the diagnostic pitfalls in the grading of epithelial dysplasia in oral potentially malignant disorders: A review.
Gupta S; Jawanda MK; Madhushankari GS
J Oral Biol Craniofac Res; 2020; 10(4):788-799. PubMed ID: 33194541
[TBL] [Abstract][Full Text] [Related]
15. Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.
Sharada P; Swaminathan U; Nagamalini BR; Kumar KV; Ashwini BK; Lavanya V
J Oral Maxillofac Pathol; 2018; 22(1):40-47. PubMed ID: 29731555
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphism of argyrophilic nucleolar organizer regions in oral submucous fibrosis and oral squamous cell carcinoma.
Khot KP; Kotak KJ; Bagri-Manjrekar K; Alex S; Choudhari SS
J Nat Sci Biol Med; 2015 Aug; 6(Suppl 1):S35-9. PubMed ID: 26604616
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
19. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.
Sarode SC; Sarode GS
Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040
[TBL] [Abstract][Full Text] [Related]
20. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
